See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Term 2 2022
| PHAR3202 | PHAR3306 | PHAR9117 | PHAR9122 |
Data is correct as at Thursday 29 September 21:51:36 AEST 2022
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR3202 | Neuropharmacology | ||||||
| CRS | CR01 | 2542 | Open | 0/25 | 0% | (Course Enrolment, UGRD) | |
| LAB | H10A | 6377 | Enr | Open | 45/52 | 87% | Thu 10-13 (w1-5,7-10, Wurth 120) |
| LAB | H10B | 6378 | Enr | Full* | 3/3 | 100% | Thu 10-13 (w1-5,7-10, Online) |
| LAB | H14A | 6379 | Enr | Open | 47/52 | 90% | Thu 14-17 (w1-5,7-10, Wurth 120) |
| LAB | H14B | 6380 | Enr | Open* | 0/3 | 0% | Thu 14-17 (w1-5,7-10, Online) |
| LAB | H14C | 6381 | Enr | Tent | 0/52 | 0% | Thu 14-17 (w1-5,7-10, Wurth 116) |
| LEC | LEC | 6388 | Auto | Open | 95/120 | 79% | |
| OTH | A | 6376 | Rel | Open | 95/120 | 79% | Tue 13 (w1-5,7-10, Online) |
| TUT | W09A | 6382 | Rel | Open | 17/35 | 49% | Wed 09 (w1-5,7-10, Mat 106) |
| TUT | W09B | 6383 | Rel | Open* | 0/1 | 0% | Wed 09 (w1-5,7-10, Online) |
| TUT | W10A | 6384 | Rel | Open | 36/40 | 90% | Wed 10 (w1-5,7-10, Mat 106) |
| TUT | W10B | 6385 | Rel | Open* | 0/2 | 0% | Wed 10 (w1-5,7-10, Online) |
| TUT | W11A | 6386 | Rel | Open | 39/40 | 98% | Wed 11 (w1-5,7-10, Mat 106) |
| TUT | W11B | 6387 | Rel | Full* | 3/3 | 100% | Wed 11 (w1-5,7-10, Online) |
| PHAR3306 | Pharmacology for Optometry | ||||||
| CRS | CR01 | 2541 | Open | 0/35 | 0% | (Course Enrolment, UGRD) | |
| LEC | A | 6389 | Rel | Open | 85/120 | 71% | |
| OTH | F11A | 6390 | Rel | Full | 20/20 | 100% | Fri 11-13 (w1-2, Wurth 115); Fri 11-13 (w3-5,7-10, Mat 101) |
| OTH | F11B | 6391 | Rel | Open | 19/20 | 95% | Fri 11-13 (w1-2, Wurth 115); Fri 11-13 (w3-5,7-10, Mat 303) |
| OTH | F11C | 6392 | Rel | Full | 20/20 | 100% | Fri 11-13 (w1-2, Wurth 115); Fri 11-13 (w3-5,7-10, Mat 302) |
| OTH | F11D | 6393 | Rel | Open* | 0/1 | 0% | Fri 11-13 (w1-2,3-5,7-10, Online) |
| OTH | F14A | 6394 | Rel | Open | 9/20 | 45% | Fri 14-16 (w1-2, Wurth 115); Fri 14-16 (w3-5,7-10, Mat 101) |
| OTH | F14B | 6395 | Rel | Open | 11/20 | 55% | Fri 14-16 (w1-2, Wurth 115); Fri 14-16 (w3-5,7-10, Mat 303) |
| OTH | F14C | 6396 | Rel | Open | 6/20 | 30% | Fri 14-16 (w1-2, Wurth 115); Fri 14-16 (w3-5,7-10, Mat 302) |
| OTH | F14D | 6397 | Rel | Open* | 0/1 | 0% | Fri 14-16 (w1-2,3-5,7-10, Online) |
| TUT | F17A | 6398 | Enr | Open | 85/120 | 71% | Fri 17 (w1-5,7-10, Online) |
| PHAR9117 | Cancer Therapeutics | ||||||
| CRS | CR01 | 1538 | Open | 0/16 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10205 | Enr | Open | 14/30 | 47% | |
| PHAR9122 | Medical Affairs | ||||||
| CRS | CR01 | 1537 | Open | 0/18 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10231 | Enr | Open | 12/30 | 40% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |